nach oben

International Ophthalmology

Erschienen in:

29.11.2022 | Original Paper

Evaluation of serum semaphorin 3A and interleukin 6 levels in patients with pseudoexfoliation syndrome

verfasst von: Murat Okutucu, Medeni Arpa

Erschienen in: International Ophthalmology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate serum semaphorin 3A (Sema3A) and interleukin 6 (IL-6) levels in pseudoexfoliation syndrome (PXS) patients to determine whether these mediators play a role in the systemic manifestations of PXS.

Methods

This prospective case–control study included 70 patients divided into PXS (n = 30) and a control group (n = 40). Serum Sema3A and IL-6 levels were analyzed using the enzyme-linked immunosorbent assay.

Results

The PXS group had a statistically higher IL-6 level [3.6(0.64–100) pg/mL], compared to the control group [2.1(0.41–39.93) pg/mL] (p < 0.05). On the other hand, the Sema3A level of the PXS group was lower at [21.55(13.2–67.5) ng/mL] compared to the control group at [29.05(11.5–103.3) ng/mL] (p < 0.05). In the PXS group, there was no correlation between the participants' IL-6 values and Sema3A, age, and body mass index (BMI) (r = 0.153, 0.000, − 0.103, respectively, all, p > 0.05), and between Sema3A values and age and BMI values (r = 0.048, − 0.133, respectively, all, p > 0.05). In the control group, there was no correlation between the participants' IL-6 values and Sema3A, age, and BMI values (r = 0.138, − 0.001, − 0.145, respectively, all, p > 0.05) and between the Sema3A and age and BMI values (r = − 0.078, − 0.281, respectively, all, p > 0.05).

Conclusions

Decreased levels of the anti-inflammatory mediator Sema3A and increased levels of inflammatory mediator IL-6 detected in PXS suggest that these molecules may play a role in systemic manifestations of this syndrome, such as inflammation, atherosclerosis, heart arrhythmia, and Alzheimer's disease.

Ritch R (2018) Ocular findings in exfoliation syndrome. J Glaucoma 27(1):67–71. https://doi.org/10.1097/IJG.0000000000000986 (PMID: 29781834)CrossRef

Helbig H, Schlötzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GOH (1994) Anterior chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 3:148–153PubMed

Naumann GOH, Schlötzer-Schrehardt U, Küchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist: intraocular and systemic manifestations. Ophthalmology 105:951–968. https://doi.org/10.1016/S0161-6420(98)96020-1CrossRefPubMed

Schlötzer-Schrehardt U, Koca M, Naumann GOH, Volkholz H (1992) Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol 110:1752–1756. https://doi.org/10.1001/archopht.1992.01080240092038CrossRefPubMed

Streeten BW, Li Z-Y, Wallace RN, Eagle RC, Keshgegian AA (1992) Pseudoexfoliative fibrillopathy in a patient with pseudoexfoliation syndrome in visceral organs. Arch Ophthalmol 110:1757–1762. https://doi.org/10.1001/archopht.1992.01080240097039CrossRefPubMed

Andrikopoulos GK, Alexopoulos DK, Gartaganis SP (2014) Pseudoexfoliation syndrome and cardiovascular diseases. World J Cardiol 6(8):847–854. https://doi.org/10.4330/wjc.v6.i8.847CrossRefPubMedPubMedCentral

Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124(5):685–687. https://doi.org/10.1016/s0002-9394(14)70908-0CrossRefPubMed

Cumurcu T, Dorak F, Cumurcu BE, Erbay LG, Ozsoy E (2013) Is there any relation between pseudoexfoliation syndrome and Alzheimer’s type dementia? Semin Ophthalmol 28(4):224–229. https://doi.org/10.3109/08820538.2013.793726CrossRefPubMed

Reniewska B, Mulak M, Misiuk-Hojło M, Kostuś E. (2004) Współistnienie choroby Alzheimera oraz zespołu rzekomego złuszczania PEX [Coexistence of Alzheimer's disease with pseudoexfoliation syndrome PEX]. Klin Oczna 106(1–2):107–9. Polish

10.

Yildirim Z, Yildirim F, Uçgun NI et al (2013) The role of the cytokines in the pathogenesis of pseudoexfoliation syndrome. Int J Ophthalmol 6:50–53. https://doi.org/10.3980/j.issn.2222-3959.2013.01.10CrossRefPubMedPubMedCentral

11.

Sorkhabi R, Ghorbanihaghjo A, Ahoor M, Nahaei M, Rashtchizadeh N (2013) High-sensitivity C-reactive protein and tumor necrosis factor alpha in pseudoexfoliation syndrome. Oman Med J 28(1):16–19. https://doi.org/10.5001/omj.2013.04CrossRefPubMedPubMedCentral

12.

Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioğlugil MO, Cağlar Y (2005) Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 243(7):677–683. https://doi.org/10.1007/s00417-004-1097-2CrossRefPubMed

13.

Adi SD, Eiza N, Bejar J et al (2019) Semaphorin 3A is effective in reducing both inflammation and angiogenesis in a mouse model of bronchial asthma. Front Immunol 10:550. https://doi.org/10.3389/fimmu.2019.00550CrossRefPubMedPubMedCentral

14.

Sumi C, Hirose N, Yanoshita M, Takano M, Nishiyama S, Okamoto Y et al (2018) Semaphorin 3A inhibits inflammation in chondrocytes under excessive mechanical stress. Mediat Inflamm 8(2018):5703651. https://doi.org/10.1155/2018/5703651CrossRef

15.

Catalano A (2010) The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. J Immunol 185(10):6373–6383. https://doi.org/10.4049/jimmunol.0903527CrossRefPubMed

16.

Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https://doi.org/10.1101/cshperspect.a016295CrossRefPubMedPubMedCentral

17.

Maachi M, Piéroni L, Bruckert E, Jardel C, Fellahi S, Hainque B et al (2004) Systemic low-grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28(8):993–997. https://doi.org/10.1038/sj.ijo.0802718CrossRefPubMed

18.

Wainstein MV, Mossmann M, Araujo GN, Gonçalves SC, Gravina GL, Sangalli M et al (2017) Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography. Diabetol Metab Syndr 6(9):67. https://doi.org/10.1186/s13098-017-0266-5CrossRef

19.

Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer’s disease. Rom J Intern Med 49(1):55–58PubMed

20.

Lepelletier Y, Moura IC, Hadj-Slimane R, Renand A, Fiorentino S, Baude C et al (2006) Immunosuppressive role of semaphorin3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 36:1782–1793. https://doi.org/10.1002/eji.200535601CrossRefPubMed

21.

Citirik M, Acaroglu G, Batman C, Yildiran L, Zilelioglu O (2007) A possible link between the pseudoexfoliation syndrome and coronary artery disease. Eye (Lond) 21(1):11–15. https://doi.org/10.1038/sj.eye.6702177CrossRefPubMed

22.

Hu S, Zhu L (2018) Semaphorins and their receptors: from axonal guidance to atherosclerosis. Front Physiol 12(9):1236. https://doi.org/10.3389/fphys.2018.01236CrossRef

23.

Wainstein MV, Mossmann M, Araujo GN, Gonçalves SC, Gravina GL, Sangalli M et al (2017) Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate-risk overweight patients referred for coronary angiography. Diabetol Metab Syndr 6(9):67. https://doi.org/10.1186/s13098-017-0266-5CrossRef

24.

Lai S, Fishman EK, Lai H, Pannu H, Detrick B (2009) Serum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the US. Inflamm Res 58(1):15–21. https://doi.org/10.1007/s00011-008-8150-2CrossRefPubMedPubMedCentral

25.

Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B (2009) How much is too much? Interleukin-6 and its signaling in atherosclerosis. Thromb Haemost 102(2):215–222. https://doi.org/10.1160/TH09-05-0297CrossRefPubMed

26.

Brajković J, Kalauz-Surać I, Ercegović A et al (2007) Ocular pseudoexfoliation syndrome and internal systemic diseases. Acta Clin Croat 46(46):57–61

27.

Hu H, Xuan Y, Xue M, Cheng W, Wang Y, Li X et al (2016) Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction. BMC Cardiovasc Disord 19(16):16. https://doi.org/10.1186/s12872-016-0192-8CrossRef

28.

Yüksel N, Karabaş VL, Arslan A, Demirci A, Cağlar Y (2001) Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108(6):1043–1049. https://doi.org/10.1016/s0161-6420(01)00572-3CrossRefPubMed

29.

Harju M, Vesti E (2001) (2001) Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol 239(4):271–277. https://doi.org/10.1007/s004170100269CrossRefPubMed

30.

Parodi MB, Bondel E, Saviano S, Ravalico G (1999) Iris fluorescein angiography and iris indocyanine green video angiography in pseudoexfoliation syndrome. Eur J Ophthalmol 9(4):284–290. https://doi.org/10.1177/112067219900900405CrossRefPubMed

31.

Ringvold A, Davanger M (1981) Iris neovascularisation in eyes with pseudoexfoliation syndrome. Br J Ophthalmol 65(2):138–141. https://doi.org/10.1136/bjo.65.2.138CrossRefPubMedPubMedCentral

32.

Park JC, Han SH (2020) Mook-Jung I (2020) Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review. BMB Rep 53(1):10–19. https://doi.org/10.5483/BMBRep.2020.53.1.309CrossRefPubMedPubMedCentral

33.

Chamarthi B, Williams GH, Ricchiuti V, Srikumar N, Hopkins PN, Luther JM, Jeunemaitre X, Thomas A (2011) Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens 24(10):1143–1148. https://doi.org/10.1038/ajh.2011.113CrossRefPubMed

34.

Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H (2007) Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 30(6):541–548. https://doi.org/10.1291/hypres.30.541CrossRefPubMed

35.

Wei J, Xu H, Davies JL, Hemmings GP (1992) Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 51(25):1953–1956. https://doi.org/10.1016/0024-3205(92)90112-3 (PMID: 1453878)CrossRefPubMed

36.

Beharka AA, Meydani M, Wu D, Leka LS, Meydani A, Meydani SN (2001) Interleukin-6 production does not increase with age. J Gerontol A Biol Sci Med Sci 56(2):B81–B88. https://doi.org/10.1093/gerona/56.2.b81CrossRefPubMed

37.

Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR (2004) Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 28(6):410–415. https://doi.org/10.1177/0148607104028006410CrossRefPubMed

38.

Piva SJ, Tatsch E, De Carvalho JA, Bochi GV, Kober H, Duarte T, Duarte MM, da Cruz IB, Moretto MB, Moresco RN (2013) Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index. Inflammation 36(1):226–231. https://doi.org/10.1007/s10753-012-9538-2CrossRefPubMed

39.

Kuo SM, Halpern MM (2011) Lack of association between body mass index and plasma adiponectin levels in healthy adults. Int J Obes (Lond) 35(12):1487–1494. https://doi.org/10.1038/ijo.2011.20CrossRefPubMed

40.

Malkov MI, Lee CTT (2021) Regulation of the hypoxia-inducible factor (HIF) by pro-inflammatory cytokines. Cells 10:2340. https://doi.org/10.3390/cells10092340CrossRefPubMedPubMedCentral

41.

Mirakaj V, Thix CA, Laucher S, Mielke C, Morote-Garcia JC, Schmit MA, Henes J, Unertl KE, Köhler D, Rosenberger P (2010) Netrin-1 dampens pulmonary inflammation during acute lung injury. Am J Respir Crit Care Med 181(8):815–824. https://doi.org/10.1164/rccm.200905-0717OCCrossRefPubMed

Titel: Evaluation of serum semaphorin 3A and interleukin 6 levels in patients with pseudoexfoliation syndrome
verfasst von: Murat Okutucu
Medeni Arpa
Publikationsdatum: 29.11.2022
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 6/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-022-02599-6

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Evaluation of serum semaphorin 3A and interleukin 6 levels in patients with pseudoexfoliation syndrome

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2023

Brain-derived neurotrophic factor levels and macular ganglion cell-inner plexiform layer thickness in macular telangiectasia type 2

Single or double? A comparison of evisceration techniques

Global trends and prospects in research of artificial cornea over past 20 years: a bibliometric and visualized analysis

Complete manuscript title: role of sub-silicone oil application of triamcinolone acetonide (TA) drops on outcomes after 360° relaxing retinectomy: a pilot study

Correlation between OCT-angiography and photopic negative response in patients with primary open angle glaucoma

Corneal biomechanical properties in vernal keratoconjunctivitis and its subtypes: a preliminary study

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde